WRBY — Warby Parker Inc. stock price and chart

WRBY

$25.62+2.52%

as of close, Oct 20, 2026

☾ AH $25.62 +2.52%

Warby Parker Inc.Stock · HealthcareRussell 2000 · 0.10% of IWMUS Stock Market · 0.004% of VTIRussell 3000 · 0.004% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Oct 1, 2021

VolumeEEEEEEEEEEE

20212023202420252026

10.015.020.025.030.035.040.045.050.055.0020.0M40.0M$25.62

2026-10-20

Price$25.62

MA20$25.42

MA50$25.16

Vol2.8M

What would $1,000 invested in WRBY be worth today? →

WRBY returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $25.62
YTD price return: +17.58%
YTD total return: +17.58%
Next earnings: Nov 5, 2026 · Before open
Market cap: 3.2B2021-09 6B2026-10 3.2B-47.3% over the window
Enterprise value: 3.1B
Shares outstanding: 123.6M2019-12 52.4M2026-06 123.6M+135.8% over the window
52W low: $14.96
52W high: $31.00
From 52W high: -17.35%
From 52W low: +71.26%
52W range: 66%

Volume

Rel volume: 0.85×
30D volume: 3.4M
30D $ vol: 84.8M

Fundamentals

Sales (ttm): 911.6M2019-12 370.5M2026-06 911.6M+146.1% over the window
Sales/share: $7.372019-12 $7.072026-06 $7.37+4.4% over the window
EPS (ttm): $0.062019-12 -$1.102026-06 $0.06-105.6% over the window
FCF (ttm): 21.7M2019-12 -11.2M2026-06 21.7M-293.5% over the window
FCF/share: $0.182019-12 -$0.212026-06 $0.18-182.1% over the window
Book value/share: $3.172019-12 -$3.612026-06 $3.17-187.8% over the window
Net margin: 0.85%2019-12 0.0%2026-06 0.8%
ROE: 1.98%2021-09 -35.2%2026-06 2.0%-105.6% over the window
ROA: 1.00%2020-12 -12.6%2026-06 1.0%-108.0% over the window
Current ratio: 2.272020-12 3.422026-06 2.27-33.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +11.00%2025-06-30 → 2026-06-30821.3M → 911.6M (+11.0% total)+12.91%2023-06-30 → 2026-06-30633.3M → 911.6M (+43.9% total)+13.34%2021-06-30 → 2026-06-30487.5M → 911.6M (+87.0% total)n/a
FCF: -58.50%2025-06-30 → 2026-06-3052.4M → 21.7M (-58.5% total)n/an/an/a
Shares: +0.85%2025-06-30 → 2026-06-30122.6M → 123.6M (+0.9% total)+1.91%2023-06-30 → 2026-06-30116.8M → 123.6M (+5.8% total)+18.01%2021-06-30 → 2026-06-3054M → 123.6M (+128.8% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +10.06%2025-06-30 → 2026-06-30$6.70 → $7.37 (+10.1% total)+10.79%2023-06-30 → 2026-06-30$5.42 → $7.37 (+36.0% total)-3.96%2021-06-30 → 2026-06-30$9.02 → $7.37 (-18.3% total)n/a
FCF/share: -58.85%2025-06-30 → 2026-06-30$0.43 → $0.18 (-58.8% total)n/an/an/a
Book value/share: +7.54%2025-06-30 → 2026-06-30$2.95 → $3.17 (+7.5% total)+7.03%2023-06-30 → 2026-06-30$2.59 → $3.17 (+22.6% total)n/an/a
Price: +17.64%2025-10-20 → 2026-10-20$21.78 → $25.62 (+17.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+22.31%2023-10-20 → 2026-10-20$14.00 → $25.62 (+83.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-14.80%2021-10-20 → 2026-10-20$57.05 → $25.62 (-55.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +17.64%2025-10-20 → 2026-10-20$21.78 → $25.62 (+17.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+22.31%2023-10-20 → 2026-10-20$14.00 → $25.62 (+83.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-14.80%2021-10-20 → 2026-10-20$57.05 → $25.62 (-55.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 415.7×2021-09 -58.482026-10 409.05-799.4% over the window
Fwd P/E: 41.0×
P/S (ttm)Market cap ÷ TTM revenue.: 3.5×2021-09 11.532026-10 3.47-69.9% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 8.1×2021-09 20.592026-10 8.08-60.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 145.6×2021-09 -298.682026-10 145.63-148.8% over the window
EV/EBITDA (fy): 56.8×
EV/Sales (ttm): 3.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 0.69%2021-09 -0.3%2026-06 0.6%-273.2% over the window
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($3.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2021-09 0.1%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($3.2B). Same caveat as the cash buyback yield.: 0.00%2021-09 0.1%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S: 67th
P/B: 68th
P/FCF: 87th

Bar = where today’s multiple sits in WRBY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.52%

-3.39%

+13.87%

+4.19%

YTD

+17.58%

+17.63%

-55.09%

Financial statements

Open full WRBY financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

WRBY — Warby Parker Inc. price, chart and key statistics